Unraveling protective effect of silymarin and silymarin nanoparticles on doxorubicin-induced cardiac toxicity via amelioration of oxidative stress, apoptosis and inflammation

Mohammed, Hanaa Hassanein, Mohammed, Sherouk Nasser, Shaker, Emad S., El-Tahawy, Nashwa Gamal Fathy, Ibrahim, Manar Fouli Gaber
Journal of Molecular Histology · Springer Nature · 2026-11-20 · DOI: 10.1007/s10735-026-11026-4

Abstract

Doxorubicin is one of the most important chemotherapies, it treats many types of cancers but it has toxic effects on heart tissue as it causes oxidative stress, apoptosis and inflammation which limits the therapeutic usage of doxorubicin as an anticancer drug. Herbal extracts as silymarin have a cardioprotective effect and silymarin nanoparticles (SiNPs) improve the poor bioavailability of silymarin. To assess a comparison between the possible protective effect of Silymarin and its nanoparticles on doxorubicin induced cardiotoxicity and to assess the possible mechanisms. Forty-eight rats were divided into four groups: Control group, Doxorubicin group (Dx-group), Silymarin treated group (s-group) and Nanosilymarin treated group (SiNPs-group). Measurement of cardiac enzymes (CK, LDH, AST and ALT), malondialdehyde (MDA) and Glutathion (GSH) in the heart tissue, and histological approaches by light microscope, transmission electron microscope and immunohistochemical study for activated -caspase 3 and IL-6 were done. Dx-group showed significant ( p < 0.05) increase in cardiac enzymes levels, significant ( p < 0.05) increase in MDA levels in cardiomyocytes and significant ( p < 0.05) decrease in GSH level compared to control group, also strong immunopositivity of IL-6 ( p < 0.05) and activated-caspase 3( p < 0.01) and histological degenerative changes in the heart tissue. These changes improved in S-group but SiNPs-group showed better findings. Doxorubicin had an apparent damaging effect on cardiac tissue structure by different mechanisms as oxidative stress, apoptosis and inflammation and co-administration with natural compounds as silymarin improves the toxic effect of doxorubicin but silymarin nanoparticles give better effect than silymarin which is suggestive of improved bioavailability and targeted delivery.

Read at publisher →

Similar articles